Table 1.
Summary of Vascular Surgery Articles
| First author |
n | Data source |
Study characteristics | Readmission, % | Mortality of readmitted patients, % |
Top 3 readmission diagnoses |
Significant predictors of readmission on multivariate analysis |
|---|---|---|---|---|---|---|---|
| Gioia (10) | < 1000 | Institutional | Patients who underwent AAA repair at a tertiary care center between 1998 and 2000 |
21% @ 6 mo | 13.6% at 6 mo |
1. Cardiovascular 2. Neoplasms 3. Respiratory |
Diabetes Non-elective AAA repair |
| Brooke (14) |
1000– 10,000 |
Medicare | Patients who were discharged home after elective TEVAR and open repair for nonruptured TAA between 2000 and 2007 |
18% at 30 d for TEVAR 20.2% at 30 d for open TAA 19.7% at 30 d overall |
NR | NR | For TEVAR: Comorbidity score renal failure pulmonary failure Shorter length of stay* For open TAA: Age Comorbidity score Shorter length of stay* |
| Greenblatt (15) |
1000– 10,000 |
Medicare | Patients who underwent elective EVAR and open AAA repair between 2004 and 2006 |
13.3% at 30 d for EVAR 12.8% at 30 d for open AAA repair 13.1% at 30 d overall |
23.4% at 1-y for readmitted 4.5% at 1-y for not readmitted |
For EVAR: 1. Wound complication 2. Pneumonia and Respiratory 3. AAA or graft For open AAA repair: 1. Wound complication 2. GI obstruction 3. Pneumonia and respiratory |
Wound complication Discharge destination Age Renal/Urologic complication History of cancer Congestive Heart Failure Anemia |
| Vogel (11) | 1000– 10,000 |
Health Facts database |
Patients who underwent lower extremity procedures for peripheral arterial disease between 2008 and 2010 |
13.9% at 30 d for open procedures 15.3% at 30 d for endovascular procedures 14.5% at 30 d overall |
NR | NR | Aspartate- aminotransferase level >30 medications ordered and dispensed Length of stay |
| Jackson (16) |
<1000 | Institutional | Patients who were discharged from the vascular surgery service at a tertiary care center between 2008 and 2009 |
8.9% at 30 d overall | NR | 1. Reintervention for bleeding, thrombosis, pseudoaneurysm, nonhealing wound 2. Groin wound complication 3. Minor amputation/wound debridement 3. Infection (urinary tract infection, pneumonia, cellulitis) |
Diabetes |
| Vogel (17) | 1000– 10,000 |
State | Patients who underwent elective EVAR and open AAA repair between 2000 and 2005 |
11.6% at 30 d for EVAR 13.1% at 30 d for open AAA repair 12.5% at 30 d overall |
NR | For EVAR: 1. Cardiac complications 2. Mechanical complications of vascular device 3. Postoperative infection For open AAA repair: 1. Rehabilitation services 2. Cardiac complications 3. Digestive system complications |
NR |
| Casey (18) |
>10,000 | State | Patients who underwent elective EVAR and open AAA repair between 2003 and 2008 |
17.4% at 30 d for EVAR 20.0% at 30 d for open AAA repair 18.5% at 30 d overall 29.7% at 90 d for EVAR 31.3% at 90 d for open AAA repair 55.4% at 1 y for EVAR 52.1% at 1 y for open AAA repair |
NR | For EVAR: 1. Cardiac 2. Infection 3. Device/aneurysm For open AAA repair: 1. Failure to thrive 2. Cardiac 3. Infection |
Sex Age Comorbidity score Insurance type Length of stay Congestive heart failure Hypertension Peripheral vascular disease* Open AAA repair* |
| McPhee (19) |
1000– 10,000 | Multicenter | Patients who underwent lower extremity vein graft bypass for critical limb ischemia between 2001–2003 |
24.4% at 30 d | NR | 1. Wound infection in index leg 2. Additional procedure in index leg 3. Nonvascular reasons |
Sex Smoking Dialysis dependence In-hospital graft event Tissue loss |
| McPhee (20) |
1000– 10,000 |
Institutional | Patients who underwent lower extremity bypasses for occlusive disease between 1995 and 2011 |
23% at 30 d | NR | 1. Wound infection 2. Unrelated medical/surgical 3. Graft related |
Postoperative surgical site infection Postoperative graft failure Postoperative myocardial infarction Current dialysis Tissue loss Congestive heart failure Distal inflow source |
| Vogel (21) | >10,000 | Medicare | Patients who underwent elective aortic, iliac, or visceral vascular procedures between 2005 and 2007 |
21.5% at 30 d for patients who did not development a postoperative infection during index hospitalization 33.7% at 30 d for patients who did develop a postoperative infection during index hospitalization 23.2% at 30 d overall |
NR | NR | Infection Race Sex |
*
Protective against readmission on multivariate analysis.
EVAR, endovascular abdominal aortic aneurysm repair; NR, not reported; TAA, thoracic aortic aneurysms; TEVAR, thoracic endovascular aneurysm repair.